Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19.
Ryo SajiMototsugu NishiiKazuya SakaiKei MiyakawaYutaro YamaokaTatsuma BanTakeru AbeYutaro OhyamaKento NakajimaTaro HiromiReo MatsumuraNaoya SuzukiHayato TaniguchiTsuyoshi OtsukaYasufumi OiFumihiro OgawaMunehito UchiyamaKohei TakahashiMasayuki IwashitaYayoi KimuraSatoshi FujiiRyosuke FuruyaTomohiko TamuraAkihide RyoIchiro TakeuchiPublished in: PloS one (2021)
Combining SpO2/FiO2 with high IL-6 and SARS-CoV-2 RNAaemia which reflect hyperinflammation and viral overload allows accurately and before intubation identifying COVID-19 patients at high risk for ECMO use or in-hospital death despite the use of MV.